↓ Skip to main content

Preventing Sleep Disruption With Bright Light Therapy During Chemotherapy for Breast Cancer: A Phase II Randomized Controlled Trial

Overview of attention for article published in Frontiers in Neuroscience, March 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
6 X users
video
1 YouTube creator

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Preventing Sleep Disruption With Bright Light Therapy During Chemotherapy for Breast Cancer: A Phase II Randomized Controlled Trial
Published in
Frontiers in Neuroscience, March 2022
DOI 10.3389/fnins.2022.815872
Pubmed ID
Authors

Michelle Rissling, Lianqi Liu, Shawn D. Youngstedt, Vera Trofimenko, Loki Natarajan, Ariel B. Neikrug, Neelum Jeste, Barbara A. Parker, Sonia Ancoli-Israel

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 8%
Student > Master 2 8%
Researcher 2 8%
Student > Ph. D. Student 2 8%
Other 1 4%
Other 2 8%
Unknown 13 54%
Readers by discipline Count As %
Nursing and Health Professions 3 13%
Psychology 3 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Business, Management and Accounting 1 4%
Physics and Astronomy 1 4%
Other 2 8%
Unknown 13 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2022.
All research outputs
#8,435,796
of 25,392,582 outputs
Outputs from Frontiers in Neuroscience
#5,347
of 11,543 outputs
Outputs of similar age
#165,742
of 446,810 outputs
Outputs of similar age from Frontiers in Neuroscience
#152
of 402 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 11,543 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,810 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 402 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.